Cellular immunotherapy for high-grade glioma
Abstract
The outcome for patients with the most common primary brain tumor, glioblastoma multiforme (GBM), remains poor. Several immunotherapeutic approaches are actively being pursued including antibodies and cell-based therapies. While the blood–brain barrier protects brain tumor cells from therapeutic antibodies, immune cells have the ability to traverse the blood–brain barrier and migrate into GBM tumors to exert their therapeutic function. Results...
Paper Details
Title
Cellular immunotherapy for high-grade glioma
Published Date
Mar 1, 2011
Journal
Volume
3
Issue
3
Pages
423 - 434
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History